Autism Disorder Treatment Market

Autism Disorder Treatment Market - Global Industry
Insights, Trends, Outlook, and Opportunity Analysis,
2018-2026
Autism, scientifically referred as autism spectrum disorder (ASD) is a range of complex
neurological disorders that is characterized by symptoms including challenges with social skills,
repetitive behaviors, as well as issues with speech and non-verbal communication. These
symptoms can vary from patient to patient suffering from the disease and thus, is known as
autism spectrum disorder. The most obvious signs of autism tend to appear in an individual
between 2-3 years of age. In certain cases, the disease can be diagnosed as early as 18 months.
The cause of autism is yet unknown, however, researchers claim that both environmental
factors and genetic changes play a pivotal role in incidence of the disorder. According to the
U.S. National Library of Medicine, there is no standard treatment currently available for
treatment of autism spectrum disorder, however, various therapies to increase the child’s ability
to grow and learn new skills are available that include communication therapies, skill training
as well as therapeutic medicines to control the symptoms of the disorder. Autism can be
diagnosed usually by a multi-disciplinary diagnostic team that often include a speech and
language therapist, a psychiatrist or psychologist, and a pediatrician.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1607
Market Dynamics
Increasing incidence of mental health illness and neurological disorders is expected to propel
growth of the autism disorder treatment market. According to the National Autistic Society
2016, around 700,000 people suffered from autism spectrum disorder in the U.K. which
accounts for 1 in every 100 people suffering from the mental condition. On a global scale, ASD
affects 1 per 160 children, according to the epidemiological data stated by the World Health
Organization (WHO), in April 2017. The WHO also suggests that based on the epidemiological
studies conducted over past 50 years, the rate of incidence of autism has witnessed an increase,
globally.
Another factor leading to growth of the autism disorder treatment market is increasing
initiatives undertaken by governments as well as non-governmental organizations for treatment
of Autism and promote the available treatment options for increasing life expectancy and
quality life of the patients. For instance, in May 2014, a resolution was adopted at the 67 th
World Health Assembly entitled “Comprehensive and Coordinated Efforts for the Management of
Autism Spectrum Disorders (ASD)” that was supported by over 60 countries across the globe, to
strengthen their national capacities to address autism spectrum disorder. Several other factors
supporting growth of the autism disorder treatment market includes development of new
medicines, growing research and development activities, increasing awareness about early
identification of disease, and others. However, stringent regulations and continuous watch
employed by governing authorities for product approval and marketing of medicines can act as
potential hindrance for growth of autism disorder treatment market. For instance, in May 2017,
the U.S. Food and Drug Administration (FDA) shut down operations of Louisiana-based Pick and
Pay Inc. /Cili Minerals, a manufacturer of drug and dietary supplements after finding that the
company was falsely marketing products to being able to treat autism.
Report includes chapters which deeply display the following deliverable about industry :
• Autism Disorder Treatment Market Research Objective and Assumption
• Autism Disorder Treatment Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Autism Disorder Treatment Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Autism Disorder Treatment Market, By Regions
• Autism Disorder Treatment Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Autism Disorder Treatment Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Autism Disorder Treatment Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Autism Disorder Treatment Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Regional Insights
On the basis of region, the global autism disorder treatment market is segmented into North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the
dominant position in the global autism disorder treatment market, owing to increasing product
development by key players in the region, rising number of autistic patients as well as
increasing government initiatives for treatment of the disease. According to Centers of Disease
Control & Prevention’s (CDC) Autism and Developmental Disabilities Monitoring (ADDM)
Network 2014, around 1 in 59 children were identified with autism spectrum disorder (ASD),
and was reported to be four times more common among boys than girls. Moreover, according
to Talk About Curing Autism (TACA), a U.S.-based non-profit organization dedicated to
supporting patients with autism, the disease is the fastest growing developmental disability in
the U.S. that cost over US$ 238 billion per year to the nation in 2016.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1607
Competitive Analysis
Key players operating in the global autism disorder treatment market include Janssen
Pharmaceuticals, Inc., Actavis, Inc., Curemark LLC, Pediatric Bioscience, Inc., Novartis AG,
Teva Pharmaceuticals Industries Ltd, Mylan NV, Pfizer, Inc., Bristol Myers Squibb, Par Sterile
Products LLC, F. Hoffman La Roche, and others. Major players are focusing on extensive
research and development to receive product approvals from the FDA and introducing new
drugs to the market. For instance, in January 2018, Switzerland-based drug maker, Roche,
received U.S. FDA grant for its breakthrough therapy, Balovaptan, for treatment of autism
spectrum disorder.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Autism, scientifically referred as autism spectrum disorder (ASD) is a range of complex neurological disorders that is characterized by symptoms including challenges with social skills

Download Report